SARS-CoV-2 vaccines in development

  title={SARS-CoV-2 vaccines in development},
  author={F. Krammer},
  • F. Krammer
  • Published 2020
  • Medicine
  • Nature
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in late 2019 in China and is the causative agent of the coronavirus disease 2019 (COVID-19) pandemic. To mitigate the effects of the virus on public health, the economy and society, a vaccine is urgently needed. Here I review the development of vaccines against SARS-CoV-2. Development was initiated when the genetic sequence of the virus became available in early January 2020, and has moved at an unprecedented speed… CONTINUE READING
    179 Citations
    Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward
    • 2
    • Highly Influenced
    SARS-CoV-2 virus: Vaccines in development
    COVID-19 vaccines: where we stand and challenges ahead
    • 2
    • Highly Influenced
    SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
    • 1


    Development of an inactivated vaccine candidate for SARS-CoV-2
    • 381
    • PDF
    A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2
    • 3
    • PDF
    Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
    • 77
    • PDF
    An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
    • 532
    • PDF
    DNA vaccine protection against SARS-CoV-2 in rhesus macaques
    • 348
    • PDF
    Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infection
    • 5
    Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques
    • 77
    • PDF
    Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
    • 236
    • PDF